Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-22
1998-09-08
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514557, 514801, 514474, 514 62, 514 54, 424417, A61K 31715, A61K 3134, A61K 3119
Patent
active
058045945
ABSTRACT:
This application relates to a pharmaceutical composition for the prevention and treatment of skin conditions in a patient having a sugar compound that is converted to a glycosaminoglycan in the patient in an amount sufficient to thicken the skin, a primary antioxidant component in an amount sufficient to substantially inhibit the formation of collagenase and elastase, at least one amino acid component in an amount sufficient to assist in the thickening of the skin, and at least one transition metal component in an amount effective to bind collagen and elastic fibers and rebuild skin. In one preferred form, the composition further includes a catechin-based preparation, a glucosamine or a pharmaceutically acceptable salt or ester thereof, and a chondroitin or a pharmaceutically acceptable salt or ester thereof. In a more preferred form, the invention further includes a vitamin E source, a cysteine source, a vitamin B.sub.3 source, quercetin dihydrate, pyridoxal 5 phosphate-Co B.sub.6, a methionine source, and a vitamin A source. The invention further relates to a method for the prevention or treatment of skin conditions by administering the pharmaceutical composition in an amount therapeutically effective to modify the thickness of the skin to prevent or treat at least one skin condition.
REFERENCES:
patent: 3232836 (1966-02-01), Carlozzi et al.
patent: 3697652 (1972-10-01), Rovati et al.
patent: 3773930 (1973-11-01), Mohammed et al.
patent: 4285964 (1981-08-01), Niebes et al.
patent: 4414202 (1983-11-01), Silvetti
patent: 4424232 (1984-01-01), Parkinson
patent: 4486416 (1984-12-01), Soll et al.
patent: 4518614 (1985-05-01), Parkinson
patent: 4642340 (1987-02-01), Senin et al.
patent: 4647453 (1987-03-01), Meisner
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4938969 (1990-07-01), Schinitsky et al.
patent: 4956173 (1990-09-01), Le Fur et al.
patent: 5153174 (1992-10-01), Band et al.
patent: 5162303 (1992-11-01), Goodman
patent: 5198465 (1993-03-01), Dioguardi
patent: 5281196 (1994-01-01), Sultenfuss
patent: 5296500 (1994-03-01), Hillebrand
patent: 5308627 (1994-05-01), Umbdenstock, Jr.
patent: 5332579 (1994-07-01), Umbdenstock
patent: 5364845 (1994-11-01), Henderson
patent: 5371089 (1994-12-01), Rattan
patent: 5415875 (1995-05-01), Kakoki et al.
patent: 5587363 (1996-12-01), Henderson
Lubell, A., "Antioxidants, Aging and the Skin", Cosmetic Dermatology, 9(7):58-60 (1996).
Neldner, K. H., "Nutrition and the Skin", Amer. Acad. Derm. Annl. Mtg., Dec. 6, 1993.
Thomas, P., "Vitamin C Eyed for Topical Use as Skin Preserver", Medical World News, Mar., 1991, p. 12.
Grevenstein, J., et al., "Cartilage Changes in Rats Induced by Papain and the Influence of Treatment With N-Acetylglucosamine", Acta Orthopaedica Belgica, 57(2):157-161 (1991).
Cerimele, D., et al., "Physiological Changes In Ageing Skin", British Journal of Dermatology (1990) 122, Supplement 35, pp. 13-20.
Reddy, G. K., et al., "Studies on the Metabolism of Glycosaminoglycans Under the Influennce of New Herbal Anti-Inflammatory Agents", Biochemical Pharmacology, 38(20):3527-3534 (1989).
Fenske, N., et al., "Structural and Functional Changes of Normal Aging Skin", Journal of the American Academy of Dermatology, 15(4):571-585, Part 1, (1986).
Setnikar, I., et al., "Pharmacokinetics of Glucosamine in the Dog and in Man", Armeim. Forsch/Drug Res. 36(1):729-733, No. 4 (1986).
Tapadinhas, M. J., et al., "Oral Glucosamine Sulphate in the Management of Arthrosis: Report on a Multi-Centre Open Investigation in Portugal", Pharmatherapeutica, 3(3):157-168 (1982).
D'Ambrosio, E., et al., "Glucosamine Sulphate: A Controlled Clinical Investigation in Arthrosis", Pharmatherapeutica, 2(8):504-508 (1981).
Drovanti, A., et al., "Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthrosis: A Placebo-Controlled Double-Blind Investigation", Clinical Therapeutics, 3(4):1-6 (1980).
Montagna, W., et al., "Structural Changes in Aging Human Skin", The Journal of Investigative Dermatology, 73(1):47-53 (1979).
Murray, M. T., "Arthritis--A Natural Solution".
Medline Abs., Swain, R., et al., "Vitamins As Therapy in the 1990's", J. American Board of Family Practice, 8(3):206-16 (1995).
Medline Abs., Todd, S., et al., "An investigation of the relationship between antioxidant vitamin intake and coronary heart disease in men and women using logistic regression analysis", J. Clinical Epidemiology, 48(2):307-16 (1995).
Medline Abs., Nachbar, F., et al., "The role of Vitamin E in normal and damaged skin", J. Molecular Medicine, 73(1):7-17 (1995).
Medline Abs., Werman, M.J., et al., "Gender, dietary copper and carbohydrate source influence cardiac Collegen and lysyl oxidase in weanling rats", J. Nutrition, 125(4):857-63 (1995).
Medline Abs., Shan, Z., et al., "Intracellular glutathione influences collagen generation by mesangial cells", Kidney International, 46(2):388-95 (1994).
Medline Abs., Maffei, F., et al., "Free radicals scavanging action and anti-enzyme activities of procyandines from Vitis vinifera. A mechanism for their capillary action", Arzneimittal-Forschung, 44(5):592-601 (1994).
Medline Abs., Oyama, Y., et al., "Myricetin and quercetin, the flavonoid constituents of Ginko Biloba extract greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons", Brain Research, 635(1-2):125-9 (1994).
Medline Abs., Asman, B., et al., "Reduction of collagen degredation in experimental granulation tissue by vitamin E and selenium", J. Clinical Periodontology, 21(1):45-7 (1994).
Medline Abs., Xie, B., et al., "Antioxident properties of fractions and polyphenol constituents from green, oolong and black teas", Life Sciences, 17(2):77-84 (1993).
Medline Abs., Parto, K., et al., "Osteoporosis in lysinuric protein intolerance", J.Inherited Metabolic Disease 16(2):441-50 (1993).
Medline Abs., Gimenez, A., et al., "Influence on dietary zinc on hepatic collagen and prolyl hydroxlase activities in alcoholic rats", Hepatology, 16(3):815-9 (1992).
Medline Abs., Reiser, K., et al., "Enzymatic and nonenzymatic cross-linking of collagen and elastin", Faseb Journal, 6(7):2439-49 (1992).
Bucci, L., et al., Glucosamine--A New Potent Nutraceutical for Connective Tissues, Nutritional Supplement Advisor, Jul. 1992.
Medline Abs., Deucher, G.P., "Antioxidant therapy in the aging process", 62:428-37 (1992).
Medline Abs., Pihlajaniemi, T., et al., "Prolyl 4-hydroxylase and its role in collagen synthesis", J. Hepatology, 13 Supp(3):S2-7 (1991).
Medline Abs., Zafirov, D., et al., "Antiexudative and capillaritonic effects of procyanidines isolated from grape seeds (V. Vinifera)", Acta Physiologica et Pharmacologica Bulgarica, 16(3):50-4 (1990).
Medline Abs., Stoss, H., "Pathologic anatomy of osteogenesis imperfecta, Light and electron microsopic studies of supportive tissue and skin", Veroffentlichungen aus der Pathologie, 134:1-88 (1990).
Kuijer, R., et al., "Influence of Constituents of Proteoglycans on Type II Collagen Fibrillogenesis", Collagen and Related Research, 5:379-91 (1985).
LandOfFree
Pharmaceutical compositions and methods for improving wrinkles a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for improving wrinkles a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for improving wrinkles a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1282423